BR112018068838A2 - oclusão de fístula pancreática - Google Patents

oclusão de fístula pancreática

Info

Publication number
BR112018068838A2
BR112018068838A2 BR112018068838A BR112018068838A BR112018068838A2 BR 112018068838 A2 BR112018068838 A2 BR 112018068838A2 BR 112018068838 A BR112018068838 A BR 112018068838A BR 112018068838 A BR112018068838 A BR 112018068838A BR 112018068838 A2 BR112018068838 A2 BR 112018068838A2
Authority
BR
Brazil
Prior art keywords
pancreatic fistula
occluding
self
assembling peptide
pancreatic
Prior art date
Application number
BR112018068838A
Other languages
English (en)
Portuguese (pt)
Inventor
Kobayashi Satoru
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of BR112018068838A2 publication Critical patent/BR112018068838A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0031—Hydrogels or hydrocolloids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
BR112018068838A 2016-03-18 2017-03-17 oclusão de fístula pancreática BR112018068838A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662310124P 2016-03-18 2016-03-18
PCT/IB2017/000366 WO2017158432A1 (en) 2016-03-18 2017-03-17 Pancreatic fistula occlusion

Publications (1)

Publication Number Publication Date
BR112018068838A2 true BR112018068838A2 (pt) 2019-01-22

Family

ID=58672629

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018068838A BR112018068838A2 (pt) 2016-03-18 2017-03-17 oclusão de fístula pancreática

Country Status (9)

Country Link
US (1) US20200078489A1 (enExample)
EP (1) EP3429646A1 (enExample)
JP (1) JP2019508175A (enExample)
CN (1) CN109152861A (enExample)
AU (1) AU2017235871A1 (enExample)
BR (1) BR112018068838A2 (enExample)
CL (1) CL2018002644A1 (enExample)
MX (1) MX2018011120A (enExample)
WO (1) WO2017158432A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190022455A (ko) 2016-03-18 2019-03-06 가부시끼가이샤 쓰리디 매트릭스 생물학적 조직 유착을 방지하는 방법
JP6912953B2 (ja) * 2016-06-27 2021-08-04 三洋化成工業株式会社 体液漏出防止剤
CN113194976A (zh) * 2018-10-05 2021-07-30 学校法人久留米大学 用于肠道中的溃疡或瘘管的治疗或预防的医药组合物
EP4112089B1 (en) * 2020-02-28 2025-12-31 Menicon Co., Ltd. DIGESTIVE FLUID LEAK PREVENTION MATERIAL AND ORGAN PROTECTION MATERIAL AGAINST DIGESTION BY DIGESTIVE FLUID
US11534528B2 (en) 2020-03-31 2022-12-27 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
CN111939323B (zh) * 2020-08-08 2022-06-10 武汉速普生物科技有限公司 含有透明质酸连接肽和连接蛋白末端肽的功能性多肽水凝胶及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080007380A (ko) * 2005-04-25 2008-01-18 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및방법
US20090186014A1 (en) * 2007-10-10 2009-07-23 Ore Pharmaceuticals Inc. Method for treatment of pancreatitis
ES2694000T3 (es) * 2008-10-06 2018-12-17 3-D Matrix Ltd. Tapón de tejido
EP2968654A1 (en) * 2013-03-14 2016-01-20 3-D Matrix, Ltd Treatment for bile leakage
CN105342984A (zh) * 2014-08-21 2016-02-24 中国人民解放军总医院 一种用于治疗急性胰腺炎的可注射温敏凝胶制剂

Also Published As

Publication number Publication date
CL2018002644A1 (es) 2019-07-05
JP2019508175A (ja) 2019-03-28
WO2017158432A1 (en) 2017-09-21
AU2017235871A1 (en) 2018-09-27
CN109152861A (zh) 2019-01-04
MX2018011120A (es) 2019-03-28
US20200078489A1 (en) 2020-03-12
EP3429646A1 (en) 2019-01-23

Similar Documents

Publication Publication Date Title
BR112018068838A2 (pt) oclusão de fístula pancreática
MX2015009963A (es) Metodos y composición farmacéutica para el tratamiento y la prevención de cardiomiopatía debido a falta de energía.
CO2020001627A2 (es) Composiciones de aminoácidos para el tratamiento de lesión neuronal
CL2018000238A1 (es) Mezcla de péptidos (divisional solicitud 201601405)
CL2021000516A1 (es) Anticuerpos y/o fragmentos de los mismos que se unen específicamente a tau humano; ácidos nucleicos que los codifican; vector; células; método para producir los anticuerpos; composición farmacéutica; y uso de los mismos para inhibir la agregación de tau, y enfermedades asociadas (divisional de la solicitud no. 202001003)
PE20191136A1 (es) Composiciones de aminoacidos y metodos de tratamiento de enfermedades hepaticas
MX2023000745A (es) Composiciones para usarse en el suministro de agentes biomacromoleculares.
BR112018010683A8 (pt) ?composição, método para produzir uma composição, método que compreende administrar por via enteral uma substância e método para produzir um produto?
BR112016011224A2 (pt) Formulação líquida de uma proteína de fusão que compreende tnfr e região de fc
MX2020001765A (es) Composiciones de aminoacidos para el tratamiento de enfermedad hepatica.
BR112015020235A2 (pt) fragmento biologicamente ativo de proteína csf-1 ou um seu homólogo, ácido nucléico, proteína de fusão, ácido nucléico isolado, vetor, célula hospedeira, método de realização da proteína de fusão do primeiro aspeto da invenção, composição, utilização de uma proteína de fusão, método de tratamento para um indivíduo sofrendo de cancro do fígado e que irá ser submetido a cirurgia, método de tratamento para um indivíduo que irá ser submetido a cirurgia de transplante de fígado, e, kit
BR112015009037A2 (pt) composição farmacêutica para uso no tratamento de infarto do miocárdio e uso de um peptídeo de fragmento de hmgb1
BR112017009584A2 (pt) tratamento de retinite pigmentosa com n-acetilcisteína amida
BR112018010160A2 (pt) inibidor da c1 esterase humana recombinante e usos do mesmo
EP4553065A3 (en) Novel compounds for treating mitochondrial disease
BR112017008962A2 (pt) proteínas de fusão inibidoras de c1 esterase e usos das mesmas
CL2021001096A1 (es) Métodos para tratar el síndrome mielodisplásico. (divisional de la solicitud no. 202000196)
MX2016007534A (es) Composicion de gel de acido hialuronico que tiene durabilidad.
BR112019006735A2 (pt) compostos e métodos para ativação da sinalização de tie2
BR112018068941A2 (pt) prevenção de adesão de tecidos biológicos
MX2019005979A (es) Peptidos modificados.
BR112018008769A2 (pt) formulações farmacêuticas, formulações líquidas aquosa reconstituída e liofilizada, seringa, método de fabricação de uma formulação farmacêutica, método para tratamento de uma doença e uso de uma formulação reconstruída
BR112016023519A2 (pt) inibidor de sinalização de wnt/ß-catenina, composição farmacêutica e método de tratamento e/ou prevenção de uma patologia definida por malformação vascular
MX2017009325A (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
BR112018071214A2 (pt) peptídeo para uso no tratamento, melhora ou prevenção de osteoartrite

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements